Effects of low - dose aspirin on clinic and ambulatory blood pressure <font color="blue">in_1</font> <font color="blue">treated_4</font> <font color="blue">hypertensive_4</font> <font color="blue">patients_4</font> <font color="blue">._4</font> Collaborative Group of the Primary Prevention Project ( PPP)--Hypertension study . 
<br>
<br> <font color="blue">Nonsteroidal_1</font> <font color="blue">antiinflammatory_1</font> <font color="blue">drugs_1</font> <font color="blue">may_1</font> <font color="blue">affect_1</font> <font color="blue">blood_1</font> <font color="blue">pressure_1</font> <font color="blue">(_1</font> <font color="blue">BP_1</font> <font color="blue">)_1</font> <font color="blue">control_1</font> <font color="blue">in_1</font> <font color="blue">hypertensive_4</font> <font color="blue">patients_4</font> <font color="blue">receiving_4</font> <font color="blue">drug_4</font> <font color="blue">treatment_4</font> <font color="blue">,_4</font> but data on the effects of low - dose aspirin are scanty . This study assessed the effects of chronic treatment with low doses of aspirin ( 100 mg / day ) on clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP in <font color="blue">hypertensives_1</font> <font color="blue">on_1</font> <font color="blue">chronic_1</font> <font color="blue">,_1</font> <font color="blue">stable_1</font> <font color="blue">antihypertensive_1</font> <font color="blue">therapy_1</font> <font color="blue">._1</font> The study was conducted in the framework of the Primary Prevention Project ( PPP ) , a randomized , controlled factorial trial on <font color="blue">the_1</font> <font color="blue">preventive_1</font> <font color="blue">effect_1</font> <font color="blue">of_1</font> <font color="blue">aspirin_1</font> <font color="blue">or_1</font> <font color="blue">vitamin_1</font> <font color="blue">E_1</font> <font color="blue">in_1</font> <font color="blue">people_2</font> <font color="blue">with_2</font> <font color="blue">one_2</font> <font color="blue">or_2</font> <font color="blue">more_2</font> <font color="blue">cardiovascular_2</font> <font color="blue">risk_2</font> <font color="blue">factors_2</font> <font color="blue">._2</font> <font color="blue">Fifteen_4</font> <font color="blue">Italian_5</font> <font color="blue">hypertension_4</font> <font color="blue">units_4</font> <font color="blue">studied_4</font> <font color="blue">142_7</font> <font color="blue">hypertensive_7</font> <font color="blue">patients_7</font> <font color="blue">(_7</font> <font color="blue">76_7</font> <font color="blue">men_7</font> <font color="blue">,_7</font> <font color="blue">66_7</font> <font color="blue">women_7</font> <font color="blue">;_7</font> <font color="blue">mean_7</font> <font color="blue">age_7</font> <font color="blue">59_7</font> <font color="blue">+_7</font> <font color="blue">/-_7</font> <font color="blue">5.9_7</font> <font color="blue">years_7</font> <font color="blue">)_7</font> <font color="blue">treated_4</font> <font color="blue">with_4</font> <font color="blue">different_4</font> <font color="blue">antihypertensive_4</font> <font color="blue">drugs_4</font> <font color="blue">:_4</font> <font color="blue">71_2</font> <font color="blue">patients_2</font> <font color="blue">were_2</font> <font color="blue">randomized_2</font> <font color="blue">to_2</font> <font color="blue">aspirin_2</font> <font color="blue">and_2</font> <font color="blue">71_2</font> <font color="blue">served_2</font> <font color="blue">as_2</font> <font color="blue">controls_2</font> <font color="blue">._2</font> <font color="blue">All_2</font> <font color="blue">patients_2</font> <font color="blue">underwent_2</font> <font color="blue">a_2</font> <font color="blue">clinic_2</font> <font color="blue">BP_2</font> <font color="blue">evaluation_2</font> <font color="blue">with_1</font> <font color="blue">an_1</font> <font color="blue">automatic_1</font> <font color="blue">sphygmomanometer_1</font> <font color="blue">and_1</font> <font color="blue">a_1</font> <font color="blue">24-h_1</font> <font color="blue">ambulatory_1</font> <font color="blue">BP_1</font> <font color="blue">monitoring_1</font> <font color="blue">,_1</font> <font color="blue">at_1</font> <font color="blue">baseline_1</font> <font color="blue">and_1</font> <font color="blue">after_1</font> <font color="blue">3_1</font> <font color="blue">months_1</font> <font color="blue">of_1</font> <font color="blue">aspirin_1</font> <font color="blue">treatment_1</font> <font color="blue">._1</font> At the end of the study the changes in clinic SBP and DBP were not statistically different in treated and untreated subjects . Ambulatory SBP and DBP after 3 months of aspirin treatment were similar to baseline : deltaSBP -0.5 mmHg ( 95% confidence intervals [ CI ] from -1.9 to + 2.9 mm Hg ) and deltaDBP -1.1 mm Hg ( 95% CI from -2.5 to + 0.3 mm Hg ) . The pattern was similar in the control group . No interaction was found between aspirin and the most used antihypertensive drug classes ( angiotensin converting enzyme inhibitors and calcium antagonists ) . Despite the relatively small sample size our results seem to exclude any significant influence of low - dose aspirin on BP control in <font color="blue">hypertensives_1</font> <font color="blue">under_1</font> <font color="blue">treatment_1</font> <font color="blue">._1</font>